{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:37:56Z","timestamp":1789504676676,"version":"build-2803163510"},"reference-count":94,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1210\/jc.2018-01008","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T18:04:21Z","timestamp":1534788261000},"page":"2463-2472","source":"Crossref","is-referenced-by-count":46,"title":["New Avenues in the Regulation of Gallbladder Motility\u2014Implications for the Use of Glucagon-Like Peptide\u2013Derived Drugs"],"prefix":"10.1210","volume":"104","author":[{"given":"Ida M","family":"Gether","sequence":"first","affiliation":[{"name":"Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Nex\u00f8e-Larsen","sequence":"additional","affiliation":[{"name":"Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-5034","authenticated-orcid":false,"given":"Filip K","family":"Knop","sequence":"additional","affiliation":[{"name":"Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Novo Nordisk Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"issue":"4","key":"2019051419194315400_B1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI111809","article-title":"Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction","volume":"75","author":"Liddle","year":"1985","journal-title":"J Clin Invest"},{"issue":"12","key":"2019051419194315400_B2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2362.1992.tb01453.x","article-title":"Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man","volume":"22","author":"Beglinger","year":"1992","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"2019051419194315400_B3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"2019051419194315400_B4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI107400","article-title":"Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function","volume":"52","author":"Malagelada","year":"1973","journal-title":"J Clin Invest"},{"issue":"2","key":"2019051419194315400_B5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI108493","article-title":"Regulation of pancreatic and gallbladder functions by intraluminal fatty acids and bile acids in man","volume":"58","author":"Malagelada","year":"1976","journal-title":"J Clin Invest"},{"issue":"5418","key":"2019051419194315400_B6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"5","key":"2019051419194315400_B7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"issue":"3","key":"2019051419194315400_B8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig Dis"},{"issue":"5","key":"2019051419194315400_B9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019051419194315400_B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"issue":"4","key":"2019051419194315400_B11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"issue":"8","key":"2019051419194315400_B12","doi-asserted-by":"crossref","first-page":"e0136873","DOI":"10.1371\/journal.pone.0136873","article-title":"Novel small molecule agonist of TGR5 possesses anti-diabetic effects but causes gallbladder filling in mice","volume":"10","author":"Briere","year":"2015","journal-title":"PLoS One"},{"key":"2019051419194315400_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2014.05.031","article-title":"4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists","volume":"82","author":"Zou","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2019051419194315400_B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1389203043486946","article-title":"Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator","volume":"5","author":"Thulesen","year":"2004","journal-title":"Curr Protein Pept Sci"},{"issue":"6","key":"2019051419194315400_B15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"2019051419194315400_B16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11695-016-2264-3","article-title":"A prospective study of the conservative management of asymptomatic preoperative and postoperative gallbladder disease in bariatric surgery","volume":"27","author":"Pineda","year":"2017","journal-title":"Obes Surg"},{"issue":"2","key":"2019051419194315400_B17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.suc.2014.01.003","article-title":"Biliary issues in the bariatric population","volume":"94","author":"Grover","year":"2014","journal-title":"Surg Clin North Am"},{"issue":"6","key":"2019051419194315400_B18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmet.2017.03.006","article-title":"Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway","volume":"6","author":"Yusta","year":"2017","journal-title":"Mol Metab"},{"key":"2019051419194315400_B19","unstructured":"Nex\u00f8e-Larsen CC , S\u00f8rensenPH, HausnerH, AgersnapM, BaekdalM, Br\u00f8ndenA, GustafssonLN, SonneDP, VedtofteL, Vilsb\u00f8llT, KnopFK. Effects of liraglutide on gallbladder emptying: a randomized, placebo-controlled trial in adults with overweight or obesity [published online ahead of print 12 June 2018]. Diabetes Obes Metab. doi: org.\/10.1111\/dom.13420."},{"key":"2019051419194315400_B20","unstructured":"Gether IM , Nex\u00f8e-LarsenC, KnopFK. Data from: New avenues in the regulation of gallbladder motility\u2014implications for the use of glucagon-like peptide\u2013derived drugs. Figshare Repository 2018. Deposited 30 June 2018. https:\/\/doi.org\/10.6084\/m9.figshare.6726839.v1."},{"issue":"2","key":"2019051419194315400_B21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11894-004-0043-0","article-title":"Smooth muscle function and dysfunction in gallbladder disease","volume":"6","author":"Portincasa","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"2019051419194315400_B22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.1902.sp000920","article-title":"The mechanism of pancreatic secretion","volume":"28","author":"Bayliss","year":"1902","journal-title":"J Physiol"},{"key":"2019051419194315400_B23","unstructured":"Ivy AC , OldbergE. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol. 1928;86:559\u2013613."},{"key":"2019051419194315400_B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2017.00047","article-title":"Cholecystokinin\u2014from local gut hormone to ubiquitous messenger","volume":"8","author":"Rehfeld","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2019051419194315400_B25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/cphy.c150050","article-title":"Functions of the gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"issue":"7943","key":"2019051419194315400_B26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(75)90297-4","article-title":"Identification of cholecystokinin-secreting cells","volume":"2","author":"Polak","year":"1975","journal-title":"Lancet"},{"issue":"4","key":"2019051419194315400_B27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0016-5085(76)80490-8","article-title":"Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa","volume":"70","author":"Buffa","year":"1976","journal-title":"Gastroenterology"},{"issue":"4","key":"2019051419194315400_B28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-14-0309","article-title":"Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1","volume":"171","author":"Sonne","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019051419194315400_B29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2170\/jjphysiol.51.585","article-title":"Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice","volume":"51","author":"Suzuki","year":"2001","journal-title":"Jpn J Physiol"},{"issue":"11","key":"2019051419194315400_B30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"2019051419194315400_B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0029(19971001)39:1<1::AID-JEMT1>3.0.CO;2-R","article-title":"Innervation of the gallbladder: structure, neurochemical coding, and physiological properties of guinea pig gallbladder ganglia","volume":"39","author":"Mawe","year":"1997","journal-title":"Microsc Res Tech"},{"issue":"3","key":"2019051419194315400_B32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1440-1746.2002.02699.x","article-title":"Endothelin-3 induces both human and opossum gallbladder contraction mediated mainly by endothelin-B receptor subtype in vitro","volume":"17","author":"Al-Jiffry","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2019051419194315400_B33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/ar.a.20089","article-title":"Innervation of the extrahepatic biliary tract","volume":"280","author":"Balemba","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"issue":"2","key":"2019051419194315400_B34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s004410050589","article-title":"Structure and chemical coding of human, canine and opossum gallbladder ganglia","volume":"284","author":"Talmage","year":"1996","journal-title":"Cell Tissue Res"},{"issue":"6","key":"2019051419194315400_B35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/BF01540263","article-title":"Contractile response of canine gallbladder and sphincter of Oddi to substance P and related peptides in vitro","volume":"34","author":"Guo","year":"1989","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2019051419194315400_B36","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.bjp.0706006","article-title":"Cyclic AMP-mediated inhibition of gallbladder contractility: role of K+ channel activation and Ca2+ signaling","volume":"143","author":"Morales","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2019051419194315400_B37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(97)01036-7","article-title":"Cyclic AMP modulates part of the relaxant action of calcitonin gene-related peptide in guinea pig gallbladder strips","volume":"72","author":"Kline","year":"1997","journal-title":"Regul Pept"},{"issue":"3","key":"2019051419194315400_B38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0016-5085(97)70189-6","article-title":"Gallbladder relaxation in patients with pigment and cholesterol stones","volume":"113","author":"Chen","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"2019051419194315400_B39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1997.tb00418.x","article-title":"Nitric oxide synthase in neurons of the human gall-bladder and its colocalization with neuropeptides","volume":"12","author":"Uemura","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2019051419194315400_B40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0016-5085(87)90961-9","article-title":"Effects of somatostatin on gallbladder emptying","volume":"92","author":"Fisher","year":"1987","journal-title":"Gastroenterology"},{"issue":"6","key":"2019051419194315400_B41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00000658-198506000-00002","article-title":"The role of neurotensin in human gallbladder motility","volume":"201","author":"Walker","year":"1985","journal-title":"Ann Surg"},{"issue":"2","key":"2019051419194315400_B42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-2275(20)41693-1","article-title":"Cholesterol 7 alpha-hydroxylase","volume":"18","author":"Myant","year":"1977","journal-title":"J Lipid Res"},{"issue":"2","key":"2019051419194315400_B43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156652407780059168","article-title":"Enzymes in the conversion of cholesterol into bile acids","volume":"7","author":"Norlin","year":"2007","journal-title":"Curr Mol Med"},{"key":"2019051419194315400_B44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"},{"key":"2019051419194315400_B45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2017.01.006","article-title":"Bile acids and their receptors","volume":"56","author":"Martinot","year":"2017","journal-title":"Mol Aspects Med"},{"issue":"5","key":"2019051419194315400_B46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(71)90283-X","article-title":"Concentrating function of the gallbladder","volume":"51","author":"Wheeler","year":"1971","journal-title":"Am J Med"},{"issue":"1","key":"2019051419194315400_B47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.34.1.47","article-title":"The concentrating activity of the gall bladder","volume":"34","author":"Rous","year":"1921","journal-title":"J Exp Med"},{"issue":"8","key":"2019051419194315400_B48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"2019051419194315400_B49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap\u2014bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2019051419194315400_B50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J Exp Med"},{"issue":"1","key":"2019051419194315400_B51","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00137.2010","article-title":"Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes","volume":"299","author":"Knop","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"2019051419194315400_B52","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/ijo.2015.115","article-title":"The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review","volume":"39","author":"Penney","year":"2015","journal-title":"Int J Obes"},{"issue":"2","key":"2019051419194315400_B53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00006676-199003000-00002","article-title":"Effect of ursodeoxycholic acid (UDCA) on pancreatic enzyme secretion and gallbladder emptying","volume":"5","author":"Lanzini","year":"1990","journal-title":"Pancreas"},{"issue":"6","key":"2019051419194315400_B54","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0016-5085(90)90487-L","article-title":"Gallbladder motility in cholesterol gallstone disease: effect of ursodeoxycholic acid administration and gallstone dissolution","volume":"99","author":"Festi","year":"1990","journal-title":"Gastroenterology"},{"issue":"5","key":"2019051419194315400_B55","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0016-5085(97)70053-2","article-title":"Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro","volume":"112","author":"Xu","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"2019051419194315400_B56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gut.50.5.669","article-title":"Intraduodenal conjugated bile salts exert negative feedback control on gall bladder emptying in the fasting state without affecting cholecystokinin release or antroduodenal motility","volume":"50","author":"van Ooteghem","year":"2002","journal-title":"Gut"},{"issue":"3","key":"2019051419194315400_B57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000078153","article-title":"Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity","volume":"69","author":"Neubrand","year":"2004","journal-title":"Digestion"},{"issue":"1","key":"2019051419194315400_B58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9610(89)90414-5","article-title":"Down-regulation of pancreatic growth and gallbladder contractility by bile salts","volume":"157","author":"Gomez","year":"1989","journal-title":"Am J Surg"},{"issue":"6 Pt 1","key":"2019051419194315400_B59","first-page":"G988","article-title":"Bile salt-dependent inhibition of gallbladder emptying","volume":"269","author":"Lin","year":"1995","journal-title":"Am J Physiol"},{"issue":"5","key":"2019051419194315400_B60","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2982.2002.00356.x","article-title":"Effects of ileal bile salts on fasting small intestinal and gallbladder motility","volume":"14","author":"Van Ooteghem","year":"2002","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"2019051419194315400_B61","first-page":"105","article-title":"Effect of bile salts on in vitro gallbladder motility: preliminary study","volume":"28","author":"Stolk","year":"1996","journal-title":"Ital J Gastroenterol"},{"issue":"3","key":"2019051419194315400_B62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1540\/jsmr1965.26.143","article-title":"Possible mechanisms of spasmolytic action of bile salts on the isolated guinea-pig gallbladder","volume":"26","author":"Sunagane","year":"1990","journal-title":"Nippon Heikatsukin Gakkai Zasshi"},{"issue":"6","key":"2019051419194315400_B63","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/hep.510280602","article-title":"Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans","volume":"28","author":"Thimister","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"2019051419194315400_B64","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0016-5085(90)90977-9","article-title":"Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects","volume":"99","author":"van Erpecum","year":"1990","journal-title":"Gastroenterology"},{"issue":"2","key":"2019051419194315400_B65","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0016-5085(92)90113-D","article-title":"Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans","volume":"102","author":"Palasciano","year":"1992","journal-title":"Gastroenterology"},{"issue":"10","key":"2019051419194315400_B66","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2362.1995.tb01953.x","article-title":"Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects","volume":"25","author":"Portincasa","year":"1995","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"2019051419194315400_B67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11892-014-0482-4","article-title":"Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes","volume":"14","author":"Hansen","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"3","key":"2019051419194315400_B68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.smj.0000208120.73327.db","article-title":"Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review","volume":"99","author":"Insull","year":"2006","journal-title":"South Med J"},{"issue":"7","key":"2019051419194315400_B69","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s10620-005-2765-8","article-title":"Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia","volume":"50","author":"Donovan","year":"2005","journal-title":"Dig Dis Sci"},{"key":"2019051419194315400_B70","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1365-2362.1990.tb01778.x","article-title":"Role of bile acids in the control of pancreatic secretion and CCK release","volume":"20","author":"Koop","year":"1990","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2019051419194315400_B71","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0016-5085(88)90564-1","article-title":"Regulation of the release of cholecystokinin by bile salts in dogs and humans","volume":"94","author":"Gomez","year":"1988","journal-title":"Gastroenterology"},{"issue":"5","key":"2019051419194315400_B72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2982.2000.00217.x","article-title":"Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans","volume":"12","author":"Portincasa","year":"2000","journal-title":"Neurogastroenterol Motil"},{"issue":"5418","key":"2019051419194315400_B73","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"4","key":"2019051419194315400_B74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"issue":"6","key":"2019051419194315400_B75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lund\u00e5sen","year":"2006","journal-title":"J Intern Med"},{"issue":"11","key":"2019051419194315400_B76","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"2019051419194315400_B77","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"2019051419194315400_B78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation","volume":"398","author":"Vassileva","year":"2006","journal-title":"Biochem J"},{"issue":"6","key":"2019051419194315400_B79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2010-0460","article-title":"The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling","volume":"25","author":"Li","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"Pt 17","key":"2019051419194315400_B80","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1113\/jphysiol.2010.192146","article-title":"Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels","volume":"588","author":"Lavoie","year":"2010","journal-title":"J Physiol"},{"issue":"3","key":"2019051419194315400_B81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"issue":"2","key":"2019051419194315400_B82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-017-4450-9","article-title":"Enteroendocrine K and L cells in healthy and type 2 diabetic individuals","volume":"61","author":"Jorsal","year":"2018","journal-title":"Diabetologia"},{"issue":"10","key":"2019051419194315400_B83","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1021\/acs.jmedchem.6b01873","article-title":"Topical intestinal aminoimidazole agonists of G-protein-coupled bile acid receptor 1 promote glucagon like peptide-1 secretion and improve glucose tolerance","volume":"60","author":"Lasalle","year":"2017","journal-title":"J Med Chem"},{"key":"2019051419194315400_B84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/dom.12636","article-title":"Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5)","volume":"5","author":"Hodge","year":"2016","journal-title":"Diabetes Obes Metab."},{"issue":"12","key":"2019051419194315400_B85","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.numecd.2014.07.014","article-title":"Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry","volume":"24","author":"Montilla","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2019051419194315400_B86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"2019051419194315400_B87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jcpt.12373","article-title":"Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database","volume":"41","author":"Pizzimenti","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2019051419194315400_B88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0016-5085(88)90307-1","article-title":"Impairment of gallbladder emptying in diabetes mellitus","volume":"95","author":"Stone","year":"1988","journal-title":"Gastroenterology"},{"issue":"3","key":"2019051419194315400_B89","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF01316504","article-title":"Gallbladder dysfunction in diabetes mellitus","volume":"38","author":"Shaw","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"1-3","key":"2019051419194315400_B90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2012.08.005","article-title":"Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects","volume":"179","author":"Keller","year":"2012","journal-title":"Regul Pept"},{"issue":"12","key":"2019051419194315400_B91","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/dom.12748","article-title":"Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients","volume":"18","author":"Smits","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"2019051419194315400_B92","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/jcph.940","article-title":"Effect of albiglutide on cholecystokinin-induced gallbladder emptying in healthy individuals: a randomized crossover study","volume":"57","author":"Shaddinger","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"2019051419194315400_B93","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2019051419194315400_B94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/7\/2463\/28646969\/jc.2018-01008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:25:15Z","timestamp":1661808315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/7\/2463\/5075997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":94,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,8,20]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01008","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,8,20]]}}}